Cargando…
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
Telomere maintenance is necessary to maintain cancer cell unlimited viability. However, the mechanisms maintaining telomere length in colorectal cancer (CRC) have not been extensively investigated. Telomere maintenance mechanisms (TMM) include the re-expression of telomerase or alternative lengtheni...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911751/ https://www.ncbi.nlm.nih.gov/pubmed/36759506 http://dx.doi.org/10.1038/s41419-023-05640-3 |
_version_ | 1784885057726447616 |
---|---|
author | Falcinelli, Marta Dell’Omo, Giulia Grassi, Elena Mariella, Elisa Leto, Simonetta Maria Scardellato, Sharon Lorenzato, Annalisa Arena, Sabrina Bertotti, Andrea Trusolino, Livio Bardelli, Alberto d’Adda di Fagagna, Fabrizio |
author_facet | Falcinelli, Marta Dell’Omo, Giulia Grassi, Elena Mariella, Elisa Leto, Simonetta Maria Scardellato, Sharon Lorenzato, Annalisa Arena, Sabrina Bertotti, Andrea Trusolino, Livio Bardelli, Alberto d’Adda di Fagagna, Fabrizio |
author_sort | Falcinelli, Marta |
collection | PubMed |
description | Telomere maintenance is necessary to maintain cancer cell unlimited viability. However, the mechanisms maintaining telomere length in colorectal cancer (CRC) have not been extensively investigated. Telomere maintenance mechanisms (TMM) include the re-expression of telomerase or alternative lengthening of telomeres (ALT). ALT is genetically associated with somatic alterations in alpha-thalassemia/mental retardation X-linked (ATRX) and death domain-associated protein (DAXX) genes. Cells displaying ALT present distinctive features including C-circles made of telomeric DNA, long and heterogenous telomeric tracts, and telomeric DNA co-localized with promyelocytic leukemia (PML) bodies forming so-called ALT-associated PML bodies (APBs). Here, we identified mutations in ATRX and/or DAXX genes in an extensive collection of CRC samples including 119 patient-derived organoids (PDOs) and 232 established CRC cell lines. C-circles measured in CRC PDOs and cell lines showed low levels overall. We also observed that CRC PDOs and cell lines did not display a significant accumulation of APBs or long telomeres with no appreciable differences between wild-type and mutated ATRX/DAXX samples. Overall, our extensive analyses indicate that CRC is not prone to engage ALT, even when carrying genetic lesions in ATRX and/or DAXX, and support the notion that ATRX/DAXX genomic footprints are not reliable predictors of ALT. |
format | Online Article Text |
id | pubmed-9911751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99117512023-02-11 Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) Falcinelli, Marta Dell’Omo, Giulia Grassi, Elena Mariella, Elisa Leto, Simonetta Maria Scardellato, Sharon Lorenzato, Annalisa Arena, Sabrina Bertotti, Andrea Trusolino, Livio Bardelli, Alberto d’Adda di Fagagna, Fabrizio Cell Death Dis Article Telomere maintenance is necessary to maintain cancer cell unlimited viability. However, the mechanisms maintaining telomere length in colorectal cancer (CRC) have not been extensively investigated. Telomere maintenance mechanisms (TMM) include the re-expression of telomerase or alternative lengthening of telomeres (ALT). ALT is genetically associated with somatic alterations in alpha-thalassemia/mental retardation X-linked (ATRX) and death domain-associated protein (DAXX) genes. Cells displaying ALT present distinctive features including C-circles made of telomeric DNA, long and heterogenous telomeric tracts, and telomeric DNA co-localized with promyelocytic leukemia (PML) bodies forming so-called ALT-associated PML bodies (APBs). Here, we identified mutations in ATRX and/or DAXX genes in an extensive collection of CRC samples including 119 patient-derived organoids (PDOs) and 232 established CRC cell lines. C-circles measured in CRC PDOs and cell lines showed low levels overall. We also observed that CRC PDOs and cell lines did not display a significant accumulation of APBs or long telomeres with no appreciable differences between wild-type and mutated ATRX/DAXX samples. Overall, our extensive analyses indicate that CRC is not prone to engage ALT, even when carrying genetic lesions in ATRX and/or DAXX, and support the notion that ATRX/DAXX genomic footprints are not reliable predictors of ALT. Nature Publishing Group UK 2023-02-09 /pmc/articles/PMC9911751/ /pubmed/36759506 http://dx.doi.org/10.1038/s41419-023-05640-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Falcinelli, Marta Dell’Omo, Giulia Grassi, Elena Mariella, Elisa Leto, Simonetta Maria Scardellato, Sharon Lorenzato, Annalisa Arena, Sabrina Bertotti, Andrea Trusolino, Livio Bardelli, Alberto d’Adda di Fagagna, Fabrizio Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) |
title | Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) |
title_full | Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) |
title_fullStr | Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) |
title_full_unstemmed | Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) |
title_short | Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) |
title_sort | colorectal cancer patient-derived organoids and cell lines harboring atrx and/or daxx mutations lack alternative lengthening of telomeres (alt) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911751/ https://www.ncbi.nlm.nih.gov/pubmed/36759506 http://dx.doi.org/10.1038/s41419-023-05640-3 |
work_keys_str_mv | AT falcinellimarta colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT dellomogiulia colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT grassielena colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT mariellaelisa colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT letosimonettamaria colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT scardellatosharon colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT lorenzatoannalisa colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT arenasabrina colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT bertottiandrea colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT trusolinolivio colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT bardellialberto colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt AT daddadifagagnafabrizio colorectalcancerpatientderivedorganoidsandcelllinesharboringatrxandordaxxmutationslackalternativelengtheningoftelomeresalt |